However, when combined with the inactivation of the Vav1 gene, the Rasgrf2 gene deficiency promotes a two–fold increase in the development of “widespread” lymphomas, shorter latency periods for the development of the disease, and enhanced mortality/sickness rates. This evidence concerns the gene RASGRF2 and lymphoma.